The Goodyear Eagle F1 Asymmetric 3 is said to deliver 31 percent better wear performance and shorter braking distance on dry and wet roads, thereby helping drivers to stay in control and to enjoy the journey.
With proven Eagle family test wins and an original-equipment track record, including on the current Jaguar XF, it is Goodyear’s premium offering for excellent braking performance, responsive handling and control in different conditions.
The Eagle F1 Asymmetric 3 is packed with Goodyear’s latest technologies. Grip Booster Technology comprises a grip-boosting compound and adhesive resin for stickiness, to deliver strong grip for shorter braking and improved handling. Active Braking Technology increases the contact surface and grip when braking, which allows for a shorter braking distance. The new reinforced construction technology delivers a stronger, lightweight construction to improve handling, cornering performance, tread wear and fuel efficiency.
The Eagle F1 Asymmetric 3 has been tested by independent organization Dekra, which reported a strong performance in tread wear compared to other premium tyres on the market. In fact, the Goodyear Eagle F1 Asymmetric 3 is projected to offer up to 11,500km extra mileage (or +31 percent better wear performance) versus the average of three leading competitors.
Additionally, the independent TÜV Süd Benchmark Test ordered by Goodyear show that the Eagle F1 Asymmetric 3, compared to the average of three leading competitors, has a 2.6m shorter braking distance (9 percent better performance) on wet roads, a 1.3m shorter braking distance on dry roads (4 percent better performance) and 4 percent better wet handling.
The same test results also show a 10.9 percent better rolling resistance compared to the average of the three tested competitors, which represents the second best rolling resistance performance of the tyre brands tested.
The new Goodyear Eagle F1 Asymmetric 3 is available in 41 sizes, from 17-inch to 20-inch.
Buying the cheapest tyres for your car is not a good idea.